Evaluation of Stress Sensitivity and Hyperemotivity in Epilepsy Compared to and a Group of Healthy Volunteers
NCT ID: NCT03464370
Last Updated: 2018-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2018-03-08
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Emotional Processing and Memory Evaluation in Epilepsy Patients
NCT00486239
Impact of Interictal Electroencephalographic Abnormalities on the Stability of Attention in the Epilepsies
NCT03094793
Depression, Stress and Vulnerability Factors in Drug Resistant Focal Epilepsies
NCT03244345
Multi-scale Analysis of Physiological Brain Networks
NCT03912155
Localizing the Epileptogenic Zone With High Resolution Electroencephalography
NCT01090934
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
TLE-AE patients may suffer from anxiety and depression (Lv et al, 2014). In clinical practice, it has been also identified an emotional vulnerability in these patients, as they report more frequently a high sensitivity to emotional distress than other epileptic patients. They also report a change in their affect intensity or a hyperemotivity, which appeared at the onset of their epilepsy. Lanteaume et al. have linked some TLE with an increased emotional vulnerability (Emo-TLE): these TLE patients reported stress factors precipitating their seizures. They found that the Emo-TLE group was characterized by an attentional bias toward threatening stimuli versus neutral stimuli, and that this bias was noticed neither in the TLE group without emotional vulnerability nor in healthy volunteers. But they did not study amygdala structure in each group.In the large database of the Toulouse University Hospital, screening was done to retrospectively collect TLE patients with AE identified on MRI. This large database has served to establish a reading grid in order to help the visual identification of an AE.The investigators propose to these patients them a series of validated scales to test:
* The impact of emotional stress factors for precipitating seizures
* The perception of stress (PSS-10).
* Psychiatric comorbidities (anxiety, depression, post-traumatic stress disorder, emotional lability…).
The study also propose cognitive tasks to search for an attentional bias towards threatening stimuli (Emotional Stroop and modified probe test). After this, the study will assess their emotional subjective responses (valence, arousal, avoidance) through a task during which they are presented with short movies that elicit six different emotions. At the same time, the measure of the variations of their neurovegetative system in terms of blood pressure, heart rate variability and electrodermal skin conductance variability will be done.
For each TLE-AE patient, additional healthy controls will be matched (2 for testing the primary outcome, 3 for the secondary outcomes).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TLE-AE Group
30 subjects Age between 18 and 65 case-control with 2 witnesses per sex and age matched cases (within 5 years) for the evaluation of the primary endpoint. For the secondary endpoints, 3 controls will be matched for each case on gender and age (within 5 years) Measure of emotional stressors then evaluate the traumatic events and to date them with respect to the beginning of epilepsy in different populations of epileptics.
Measure of emotional stressors
For the Epileptic Group
* Rapid interrogation, completing the clinical data
* A scale of impact of the precipitating factors of crises
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A measure of the perception of emotions using film clips
* A scale of measurement of perceived stress
* The transfer of psychiatric scales
For the healthy volunteers group :
* A rapid interrogation, gathering the possible medical history, the level of studies, the manual laterality
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A scale of measurement of perceived stress
* A measure of the perception of emotions using film clips
* A rapid neuropsychological assessment
Non AE epileptic Group
30 subjects Age between 18 and 65 case-control with 2 witnesses per sex and age matched cases (within 5 years) for the evaluation of the primary endpoint. For the secondary endpoints, 3 controls will be matched for each case on gender and age (within 5 years) Measure of emotional stressors then evaluate the traumatic events and to date them with respect to the beginning of epilepsy in different populations of epileptics.
Measure of emotional stressors
For the Epileptic Group
* Rapid interrogation, completing the clinical data
* A scale of impact of the precipitating factors of crises
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A measure of the perception of emotions using film clips
* A scale of measurement of perceived stress
* The transfer of psychiatric scales
For the healthy volunteers group :
* A rapid interrogation, gathering the possible medical history, the level of studies, the manual laterality
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A scale of measurement of perceived stress
* A measure of the perception of emotions using film clips
* A rapid neuropsychological assessment
Extra-temporal epilepsy Group
30 subjects Age between 18 and 65 case-control with 2 witnesses per sex and age matched cases (within 5 years) for the evaluation of the primary endpoint. For the secondary endpoints, 3 controls will be matched for each case on gender and age (within 5 years) Measure of emotional stressors and then evaluate the traumatic events and to date them with respect to the beginning of epilepsy in different populations of epileptics.
Measure of emotional stressors
For the Epileptic Group
* Rapid interrogation, completing the clinical data
* A scale of impact of the precipitating factors of crises
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A measure of the perception of emotions using film clips
* A scale of measurement of perceived stress
* The transfer of psychiatric scales
For the healthy volunteers group :
* A rapid interrogation, gathering the possible medical history, the level of studies, the manual laterality
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A scale of measurement of perceived stress
* A measure of the perception of emotions using film clips
* A rapid neuropsychological assessment
Healthy volunteers Group
30 subjects Age between 18 and 65 case-control with 2 witnesses per sex and age matched cases (within 5 years) for the evaluation of the primary endpoint. For the secondary endpoints, 3 controls will be matched for each case on gender and age (within 5 years) Measure of emotional stressors
Measure of emotional stressors
For the Epileptic Group
* Rapid interrogation, completing the clinical data
* A scale of impact of the precipitating factors of crises
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A measure of the perception of emotions using film clips
* A scale of measurement of perceived stress
* The transfer of psychiatric scales
For the healthy volunteers group :
* A rapid interrogation, gathering the possible medical history, the level of studies, the manual laterality
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A scale of measurement of perceived stress
* A measure of the perception of emotions using film clips
* A rapid neuropsychological assessment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Measure of emotional stressors
For the Epileptic Group
* Rapid interrogation, completing the clinical data
* A scale of impact of the precipitating factors of crises
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A measure of the perception of emotions using film clips
* A scale of measurement of perceived stress
* The transfer of psychiatric scales
For the healthy volunteers group :
* A rapid interrogation, gathering the possible medical history, the level of studies, the manual laterality
* An emotional Stroop
* A task of detecting emotional targets against threatening information
* A scale of measurement of perceived stress
* A measure of the perception of emotions using film clips
* A rapid neuropsychological assessment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\- For TLE-AE: An AE identified on the MRI by an expert neuroradiologist. MRI must be less than one year.
\- For non AE epileptic patients: No AE reported in the MRI by an expert neuroradiologist.
Exclusion Criteria
* Any diabetes
* Beta-blockers
* Neuroleptics
* Any neurologic diseases for the healthy volunteers.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie DENUELLE, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Toulouse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A02853-50
Identifier Type: OTHER
Identifier Source: secondary_id
RC31/17/0276
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.